Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

Katsunori Imai, Shinya Hirata, Atsushi Irie, Satoru Senju, Yoshiaki Ikuta, Kazunori Yokomine, Michiko Harao, Mitsuhiro Inoue, Takuya Tsunoda, Shuichi Nakatsuru, Hidewaki Nakagawa, Yusuke Nakamura, Hideo Baba, Yasuharu Nishimura

Clin Cancer Res (2008) 14 (20): 6487–6495.

https://doi.org/10.1158/1078-0432.CCR-08-1086

Published: 16 October 2008

View article titled, Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

Includes: Supplementary data

Journal Articles

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Hiroyuki Komori, Tetsuya Nakatsura, Satoru Senju, Yoshihiro Yoshitake, Yutaka Motomura, Yoshiaki Ikuta, Daiki Fukuma, Kazunori Yokomine, Michiko Harao, Toru Beppu, Masanori Matsui, Toshihiko Torigoe, Noriyuki Sato, Hideo Baba, Yasuharu Nishimura

Clin Cancer Res (2006) 12 (9): 2689–2697.

https://doi.org/10.1158/1078-0432.CCR-05-2267

Published: 04 May 2006

View article titled, Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Journal Articles

Highly Sensitive Detection of Melanoma at an Early Stage Based on the Increased Serum Secreted Protein Acidic and Rich in Cysteine and Glypican-3 Levels

Yoshiaki Ikuta, Tetsuya Nakatsura, Toshiro Kageshita, Satoshi Fukushima, Shosuke Ito, Kazumasa Wakamatsu, Hideo Baba, Yasuharu Nishimura

Clin Cancer Res (2005) 11 (22): 8079–8088.

https://doi.org/10.1158/1078-0432.CCR-05-1074

Published: 18 November 2005

View article titled, Highly Sensitive Detection of Melanoma at an Early Stage Based on the Increased Serum Secreted Protein Acidic and Rich in Cysteine and Glypican-3 Levels

Journal Articles

Identification of Glypican-3 as a Novel Tumor Marker for Melanoma

Tetsuya Nakatsura, Toshiro Kageshita, Shosuke Ito, Kazumasa Wakamatsu, Mikio Monji, Yoshiaki Ikuta, Satoru Senju, Tomomichi Ono, Yasuharu Nishimura

Clin Cancer Res (2004) 10 (19): 6612–6621.

https://doi.org/10.1158/1078-0432.CCR-04-0348

Published: 08 October 2004

View article titled, Identification of Glypican-3 as a Novel Tumor Marker for Melanoma

Journal Articles

Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis

Yoshihiro Yoshitake, Tetsuya Nakatsura, Mikio Monji, Satoru Senju, Hidetake Matsuyoshi, Hirotake Tsukamoto, Seiji Hosaka, Hiroyuki Komori, Daiki Fukuma, Yoshiaki Ikuta, Toyomasa Katagiri, Yoichi Furukawa, Hiromi Ito, Masanori Shinohara, Yusuke Nakamura, Yasuharu Nishimura

Clin Cancer Res (2004) 10 (19): 6437–6448.

https://doi.org/10.1158/1078-0432.CCR-04-0841

Published: 08 October 2004

View article titled, Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis

NARROW

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Highly Sensitive Detection of Melanoma at an Early Stage Based on the Increased Serum Secreted Protein Acidic and Rich in Cysteine and Glypican-3 Levels

Identification of Glypican-3 as a Novel Tumor Marker for Melanoma

Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis

Email alerts

AACR Journals

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Highly Sensitive Detection of Melanoma at an Early Stage Based on the Increased Serum Secreted Protein Acidic and Rich in Cysteine and Glypican-3 Levels

Identification of Glypican-3 as a Novel Tumor Marker for Melanoma

Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only